The benefit of simplification from tipranavir/ritonavir 500/200 bid to 500/100 bid guided by therapeutic drug monitoring

  1. Rodríguez-Novoa, S.
  2. Morello, J.
  3. Blanco, F.
  4. Vispo, E.
  5. Barreiro, P.
  6. Gonzalez-Pardo, G.
  7. Jiménez-Nácher, I.
  8. González-Lahoz, J.
  9. Soriano, V.
Journal:
Therapeutic Drug Monitoring

ISSN: 1536-3694,  0163-4356

Year of publication: 2010

Volume: 32

Issue: 2

Pages: 242-244

Type: Article

DOI: 10.1097/FTD.0B013E3181D3F97F GOOGLE SCHOLAR

Sustainable development goals

Data source: Scopus